Dyadic International has secured a $3 million grant from the Bill & Melinda Gates Foundation to develop cost-effectiv ...

Engineered proteins are critical industrial and medical applications, ranging from vaccine development to making crops or food proteins more resilient. Scientists can engineer proteins to improve upon ...

Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children: Tokyo Saturday, November 23, 2024, 10:00 Hrs [IST] Zenyaku Ko ...

According to Alnylam’s Tim Mooney, mivelsiran’s endurance is due to stabilizing tweaks the scientists made to the siRNA ...

Nature is adept at designing proteins. Scientists are even better. But artificial intelligence holds the promise of improving ...

Dyadic international was awarded a $3 million grant from the Bill & Melinda Gates Foundation to fund the development of ...

Abu Dhabi: The UAE’s National Immunisation Programme ensures that more than 90 per cent of the population is protected ...

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...

Dyadic International (DYAI) announced that it has been awarded a $3M grant from the Gates Foundation for the cell line development of monoclonal antibodies targeting respiratory syncytial virus and ...

Cell Culture Market. The global cell culture market is poised for significant growth, with projections estimating a rise from ...

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics License Application (BLA) in the U.S. for ...